MSB 4.07% $1.15 mesoblast limited

Ann: FDA Schedules GvHD Pre-License Manufacturing Inspection, page-117

  1. 2,039 Posts.
    lightbulb Created with Sketch. 1179
    https://www.fiercepharma.com/manufacturing/fda-blasts-lonza-facility-form-483-derailed-bristol-myers-plan-liso-cel-nod-by-2020
    Fierce Bio had written something also about Lonza (Houston not Singapore) in the month before February 2021 - the date of your World's Most Ethical Company recognition "by operating with integrity every day".

    So I guess people can decide what they read. I was pretty sure I'd seen the post I'm now re posting here. here, on the HC MSB forum. I did - MJC73 posted it.

    There is a pdf report in the Fierce Bio article that I saved at the time as an example of what the FDA can report when they do a site visit. That's still there if its of interest to anyone.

 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.15
Change
0.045(4.07%)
Mkt cap ! $1.313B
Open High Low Value Volume
$1.08 $1.16 $1.08 $4.681M 4.170M

Buyers (Bids)

No. Vol. Price($)
1 99680 $1.15
 

Sellers (Offers)

Price($) Vol. No.
$1.16 31000 2
View Market Depth
Last trade - 16.10pm 19/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.